Dublin, March 10, 2025 (GLOBE NEWSWIRE) -- The "Blood Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Assay Kits And Reagents), By Test (Blood Tests, Imaging Tests, Molecular Tests), By End-use (Hospitals And Clinics), By Region, And Segment Forecasts, 2025 - 2030" report has been added to ResearchAndMarkets.com's offering.
Tue, 25 Mar 2025 14:02:00 GMT A common blood test for ovarian cancer is more likely to fall short for Black and Native American women, according to a new study. This was the case for Nefa-Tari Moore, 45, a three time "thriver" of ...
Tue, 25 Mar 2025 13:19:00 GMT (Nasdaq: VCYT), a leading cancer diagnostics company, today announced new data showing that its whole-genome sequencing (WGS)-based platform for minimal residual disease (MRD) testing detected cancer ...
Mon, 24 Mar 2025 06:45:00 GMT Primary investigator and presenter of the study, Ahmed H. Zedan, MD, PhD from Lillebaelt Hospital - University Hospital of Southern Denmark said: ”Proclarix can be safely used to reduce performed ...
Mon, 24 Mar 2025 03:00:00 GMT The test works by looking for cell-free nucleosomes in the blood. The study included 229 patients diagnosed with cancer and 150 healthy subjects. According to VolitionRx, the Nu.Q test was able to ...
Fri, 21 Mar 2025 09:00:10 GMT Subscribe today and save an extra 5% with checkout code 'LOVE5' Engaging articles, amazing illustrations & exclusive interviews Issues delivered straight to your door or device ...
